Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Non-Viral Transfection Method, Application ...
Dublin, June 23, 2020 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents and Systems Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering. Over the last few years, the ...
Despite the undeniable ability of viral vectors to deliver genetic payloads, and despite the incredible promise of this approach to treat a vast variety of diseases—including metabolic, cardiovascular ...
Recombinant adeno-associated virus (AAV) and lentiviral vectors (LV) are vehicles for direct delivery of therapeutic genes to patients' cells. In the coming years, the use of AAV and LV in clinical ...
AUSTIN, Texas, June 23, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...
No currently available treatment is able to generate new contractile tissue or significantly improve cardiac function after myocardial infarction (MI), a leading cause of morbidity and mortality ...
Viruses are experts at infiltrating the body, as the SARS-CoV-2 virus (and resulting COVID-19 pandemic) have amply demonstrated. But their efficiency in targeting specific and isolated cells also make ...
Our in-stock adenoviral vectors are available per vial of 500 ul, 100 ul, and 50 ul. 500 ul ~ 2.5 x 10e12 pt/ml 100 ul ~ 5 x 10e11 pt/ml 50 ul ~ 2.5 x 10e11 pt/ml For each Lot#, the Plaque Forming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback